Germany's Bayer has agreed to a proposed settlement of $7.25 billion to resolve thousands of US lawsuits alleging Roundup herbicide causes cancer.[2] The settlement should be paid over 21 years and should resolve current and future potential lawsuits related to this product.[3] Bayer acquired Roundup maker Monsanto in 2018 and has so far paid out about $10 billion in related cancer cases, with another $5.9 billion set aside for legal costs.[1] The company disputes claims that glyphosate—the active ingredient in Roundup—causes non-Hodgkin's lymphoma, although the World Health Organization has classified the substance as "probably carcinogenic to humans".[3] Bayer warned that rising legal costs threaten its ability to continue selling the product in US agricultural markets.[2] The settlement is still pending court approval in St. Louis in Missouri.[2]